MYH9

From WikiMD's WELLNESSPEDIA

MYH9 is a gene that encodes the non-muscle myosin heavy chain IIA protein. This protein is a major component of the contractile apparatus of the cell and is involved in various cellular processes such as cell motility, adhesion, and cytokinesis. Mutations in the MYH9 gene are associated with several autosomal dominant disorders, collectively known as MYH9-related disorders.

Function[edit]

The MYH9 gene provides instructions for making a protein called non-muscle myosin heavy chain IIA. This protein is found throughout the body and is involved in many cellular processes, including cell movement (motility), cell shape, and the division of cells (cytokinesis). The protein is also important for the formation of platelets, which are small cell fragments involved in blood clotting.

Clinical significance[edit]

Mutations in the MYH9 gene are associated with several related conditions, collectively known as MYH9-related disorders. These conditions are characterized by large platelets (macrothrombocytopenia); hearing loss; eye abnormalities; kidney disease; and/or changes in skin coloring (pigmentation). The specific features vary among affected individuals, even among members of the same family.

MYH9-related disorders[edit]

MYH9-related disorders include May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome. These conditions were once thought to be distinct disorders but are now considered to be part of the same condition spectrum because they are all caused by mutations in the MYH9 gene.

See also[edit]

References[edit]


External links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.